Astelin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Astelin
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Astelin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 14 USDMF, 7 CEP/COS, 2 JDMF, 4 EU WC, 12 KDMF, 14 NDC API, 13 Listed Suppliers, $ API Reference Price

38 API Suppliers
14 USDMF
7 CEP/COS
2 JDMF
4 EU WC
12 KDMF
14 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

30 Drugs in Development

30 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

92 FDF Dossiers, 40 FDA Orange Book, 27 Europe, 3 Canada, 3 South Africa, 19 Listed Dossiers

92 FDF Dossiers
40 FDA Orange Book
27 Europe
3 Canada
3 South Africa
19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SOLUTION/DROPS;OPHTHALMIC - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY
SOLUTION/DROPS;OPHTHALMIC - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - 0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 3 SPI Pharma, 4 DKSH, 1 Pharm-RX Chemical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 1 ACG Worldwide, 11 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 10 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 12 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 Silverline Chemicals, 3 The Dow Chemical Company, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 23 Thickeners and Stabilizers, 23 Fillers, Diluents & Binders, 21 Parenteral, 17 Film Formers & Plasticizers, 16 Controlled & Modified Release, 16 Solubilizers, 11 Taste Masking, 11 Direct Compression, 9 Rheology Modifiers, 9 Co-Processed Excipients, 7 Granulation, 6 Chewable & Orodispersible Aids, 6 Disintegrants & Superdisintegrants, 5 Empty Capsules, 5 Topical, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 3 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Lubricants & Glidants, 1 Soft Gelatin

41 Coating Systems & Additives
23 Thickeners and Stabilizers
23 Fillers, Diluents & Binders
21 Parenteral
17 Film Formers & Plasticizers
16 Controlled & Modified Release
16 Solubilizers
11 Taste Masking
11 Direct Compression
9 Rheology Modifiers
9 Co-Processed Excipients
7 Granulation
6 Chewable & Orodispersible Aids
6 Disintegrants & Superdisintegrants
5 Empty Capsules
5 Topical
4 Vegetarian Capsules
4 API Stability Enhancers
4 Emulsifying Agents
3 Surfactant & Foaming Agents
2 Coloring Agents
1 Lubricants & Glidants
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 35 News #PharmaBuzz

1 Data Compilation #PharmaFlow
35 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 20 Regulatory FDF Prices, 14 Annual Reports

19 US Medicaid Prescriptions
20 Regulatory FDF Prices
14 Annual Reports

MARKET PLACE

16 APIs, 1 FDF Dossiers

16 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

13 US Patents, 2 Health Canada Patents

13 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 13 Others

4 EDQM
13 Others

$ API Ref.Price (USD/KG) : 7,340 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2BGP Pharma ULC

filter Patent Reset all filters

2 All

01 22489427

filter Product Reset all filters

2 All

01 2AZELASTINE HYDROCHLORIDE | FLUTICASONE PROPIONATE

filter Dosage Reset all filters

2 All

01 1SPRAY

02 1SUSPENSION

filter Exp Date Reset all filters

2 All

01 22023-06-13

Coral Drugs Azelastine Hydrochloride

Product Main Page

01

BGP Pharma ULC

Azelastine Hydrochloride, Fluticasone Propionate

CPhI Korea

Not Confirmed

BGP Pharma ULC

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-06-13

Date Granted : 2012-09-25

Azelastine Hydrochloride, Fluticasone Propionate

Brand Name : DYMISTA

Patent Number : 2489427

Filing Date : 2003-06-13

Strength per Unit : 0.137 mg / 0.050 mg

Dosage Form : SPRAY

Human Or VET : Human

Route of Administration : NASAL

Patent Expiration Date : 2023-06-13

Date Granted : 2012-09-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BGP Pharma ULC

Azelastine Hydrochloride, Fluticasone Propionate

CPhI Korea

Not Confirmed

BGP Pharma ULC

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-06-13

Date Granted : 2012-09-25

Azelastine Hydrochloride, Fluticasone Propionate

Brand Name : DYMISTA

Patent Number : 2489427

Filing Date : 2003-06-13

Strength per Unit : 0.137 mg / 0.050 mg

Dosage Form : SUSPENSION

Human Or VET : Human

Route of Administration : NASAL

Patent Expiration Date : 2023-06-13

Date Granted : 2012-09-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!